Retraction: Synergistic Suppression Effect on Tumor Growth of Acute Myeloid Leukemia by Combining Cytarabine with an Engineered Oncolytic Vaccinia Virus (Onco Targets Ther. 2018;11:6887‒6900)

0Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

At the authors request, the Editor and Publisher of OncoTargets and Therapy wish to retract the published article. The authors requested to replace western blot images in Figure 4, where images for Figure 4, THP-1, CyclinD1 and THP-1, CDK2 appeared to have been duplicated. Further analysis found evidence for the manipulation of western blot images in Figure 3. Specifically, ● Images for Figure 3B, panels KG-1; HL-60; K562, p53/p100 all appear to have been duplicated and enhanced to give the appearance of being distinct western blot bands. The authors provided some original western blot data, but it was not satisfactory and was unable to adequately verify the reported findings. The authors requested to retract the article and the Editor agreed with this. We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

Cite

CITATION STYLE

APA

Peng, J., Wang, S., & Fan, W. (2022). Retraction: Synergistic Suppression Effect on Tumor Growth of Acute Myeloid Leukemia by Combining Cytarabine with an Engineered Oncolytic Vaccinia Virus (Onco Targets Ther. 2018;11:6887‒6900). OncoTargets and Therapy. Dove Medical Press Ltd. https://doi.org/10.2147/OTT.S392085

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free